HC Wainwright & Co. Reiterates Buy on Eledon Pharma, Maintains $16 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Eledon Pharma (NASDAQ:ELDN) and maintained a price target of $16.
June 04, 2024 | 10:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Eledon Pharma and maintained a price target of $16.
The reiteration of a Buy rating and a maintained price target of $16 by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100